Scoopfeeds — Intelligent news, curated.
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason
business

Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason

Yahoo Finance · Jun 23, 2026, 1:38 AM

Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason

Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop